Sympathetic system activity in obesity and metabolic syndrome

Annals of the New York Academy of Sciences

Volumn 1083, Issue , 2006, Pages 129-152

  Tentolouris, N ^a,b   Liatis, S ^a   Katsilambros, N ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

Autonomic nervous system; Metabolic syndrome; Obesity; Sympathetic; Sympathetic nervous system

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; CLONIDINE; INTERLEUKIN 6; LEPTIN; NEUROPEPTIDE Y; PROPRANOLOL; SIBUTRAMINE; TERBUTALINE;

ADRENERGIC SYSTEM; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CYTOKINE PRODUCTION; ENERGY BALANCE; ENERGY EXPENDITURE; FOOD INTAKE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPOLYSIS; MALIGNANT NEOPLASTIC DISEASE; METABOLIC RATE; METABOLIC SYNDROME X; NEUROPATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; STROKE; WEIGHT REDUCTION;

EID: 33845638270     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1367.010     Document Type: Conference Paper

References (136)

1. WORLD HEALTH ORGANIZATION. 1998. Obesity, preventing and managing the global epidemic. Geneva. WHO, 17.
2. NATIONAL TASK FORCE ON THE PREVENTION AND TREATMENT OF OBESITY. 2000. Overweight, obesity and health risk. Arch. Intern. Med. 160: 898-904.
3. REAVEN, G.M. 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607.
4. WAJCHENBERG, B.L. 2000. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr. Rev. 21: 697-738.
5. BANNISTER, R. 1982. Introduction and classification. In Autonomic Failure: a Textbook of Clinical Disorders of the Autonomic Nervous System. R. Bannister, Eds.: 3-13. Oxford Medical Publications. Oxford, UK.
6. CRYER, P.E. 1993. Adrenaline: a physiological metabolic regulatory hormone in humans? Int. J. Obes. 17(Suppl 3): S43-S46.
7. DEL RIO, G. 2000. Adrenomedullary function and its regulation in obesity. Int. J. Obes. Relat. Metab. Disord. 24(S2): S89-S91.
8. MUNTZEL, M.S., D.A. MORGAN, A.L. MARK, et al. 1994. Intracerebroventricular insulin produces nonuniform regional increases in sympathetic nerve activity. Am. J. Physiol. 267: R1350-R1355.
9. CHARMANDARI, E., C. TSIGOS & G. CHROUSOS. 2005. Endocrinology of the stress response. Annu. Rev. Physiol. 67: 259-284.
10. PLOTSKY, P.M., E.T. CUNNINGHAM Jr & E.P. WIDMAIER. 1989. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endrocr. Rev. 10: 437-458.
11. SAPER, C.B., A.D. LOWY. L.W. SWANSON, et al. 1976. Direct hypathalamo-autonomic connections. Brain Res. 117: 305-312.
12. CHROUSOS, G.P. & P.W. GOLD. 1992. The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA 267: 1244-1252.
13. HABIB, K.E., K.P. WELD, K.C. RICE, et al. 2000. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc. Natl. Acad. Sci. USA 97: 6079-6084.
14. STRATAKIS, C.A. & G.P. CHROUSOS. 1995. Neuroendocrinology and pathophysiology of the stress system. Ann. N. Y. Acad. Sci. 29: 771: 1-18.
15. UDELSMAN, R., J.A. NORTON, S.E. JELENICH, et al. 1987. Responses of the hypothalamic-pituitary-adrenal and renin-angiotensin axes and the sympathetic system during controlled surgical and anesthetic stress. J. Clin. Endocrinol. Metab. 64: 986-994.
16. LIATIS, S., N. TENTOLOURIS & N. KATSILAMBROS. 2004. Cardiac autonomic nervous system activity in obesity. Ped. Endocrinol. Rev. 1(Suppl 3): 476-483.
17. SAKAGUCHI, T., K. ARASE & G.A. BRAY. 1988. Sympathetic activity and the food intake of rats with ventromedial hypothalamic lesions. Int. J. Obes. 12: 285-291.
18. BRAY, G.A. & Y. NISHIZAWA. 1978. Ventromedial hypothalamus modulates fat mobilization during fasting. Nature 274: 900-902.
19. NIIJIMA, A., F. ROHNER-JEANRENAUD & B. JEANRENAUD. 1984. Role of ventromedial hypothalamus on sympathetic efferents of brawn adipose tissue. Am. J. Physiol. 247: R650-R654.
20. TOKUNAGA, K., M. FUKUSHIMA, J.W. KEMNITZ, et al. 1986. Effect of vagotomy on serum insulin in rats with paraventricular or ventromedial hypothalamic lesions. Endocrinology 119: 1708-1711.
21. POWELEY, T.L. & R.E. KEESEY. 1970. Relationship of body weight to the lateral hypothalamic feeding syndrome. J. Comp. Physiol. Phychol. 70: 25-36.
22. PARAMESWARAN, S.V., A.B. STEFFENS, G.R. HERVEY, et al. 1977. Involvement of a humoral factor in regulation of body weight in parabiotic rats. Am. J. Physiol. 232: R150-R157.
23. BRAY, G.A. 1991. Reciprocal relation between the sympathetic nervous system and food intake. Brain Res. Bull. 27: 517-520.
24. STANLEY, B.G., K.C. ANDERSON, M.H. GRAYSON, et al. 1989. Repeated hypothalamic stimulation with neuropeptide Y increases daily carbohydrate and fat intake and body weight gain in female rats. Physiol. Behav. 46: 173-177.
25. EGAWA, M., H. YOSHIMATSU & G.A. BRAY. 1991. Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Am. J. Physiol. 260: R328-R334.
26. KOTZ, C.M., M.K. GRACE, J. BRIGGS, et al. 1995. Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. Neural site of action. J. Clin. Invest. 96: 163-170.
27. BRAY, G.A.. 2000. Reciprocal relation of food intake and sympathetic activity: experimental observations and clinical implications. Int. J. Obes. 24(Suppl 2): S8-S17.
28. E. MCNAIR & R. BRYSON. 1983. Effects of nicotine on weight change and food consumption in rats. Pharmac. Biochem. Behav. 18: 341-344.
29. HANSEN, D.L., S. TOURBO, M.J. STOCK, et al. 1999. The effect of sibutramine on energy expenditure and appetite during chronic treatment without energy restriction. Int. J. Obes. Relat. Metab. Disord. 23: 1016-1024.
30. HIRSCH, J., R.M. MACKINTOSH & L.J. ARONNE. 2000. The effects of drugs used to treat obesity on the autonomic nervous system. Obes. Res. 8: 227-233.
31. NISOLI, E. & M.O. CARRUBA. 2000. An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action. Obes. Rev. 1: 127-139.
32. HANSEN, D.L., S. TOURBO, M.J. STOCK, et al. 1998. Thermogenic effects of sibutramine in humans. Am. J. Clin. Nutr. 69: 1180-1186.
33. TSUJII, S. & G.A. BRAY. 1998. A β3-adrenergic agonist (BRL-37344) decreases food intake. Physiol. Behav. 63: 723-728.
34. CARULLI, L., S. FERRARI, M. BERTOLINI, et al. 1999. Regulation of ob gene expression: evidence for epinephrine-induced suppression in human obesity. J. Clin. Endocrinol. Metab. 84: 3309-3312.
35. TRAYHURN, P., J.S. DUNCAN & D.V. RAYNER. 1995. Acute cold induced suppression of ob (obese) gene expression in white adipose tissue of mice: mediation by the sympathetic system. Biochem. J. 311: 729-733.
36. RAVUSSIN, E. & B.A. SWINBURN. 1996. Energy expenditure and obesity. Diab. Rev. 4: 403-422.
37. RAVUSSIN, E., S. LILLIOJA, W.C. KNOWLER, et al. 1988. Reduced rate of energy expenditure as a risk factor for body-weight gain. N. Engl. J. Med. 318: 467-472.
38. CORI, C.F. & K.W. BUCHWALD. 1930. Effect of continuous injection of epinephrine on the carbohydrate metabolism, basal metabolism and vascular system of normal men. Am. J. Physiol. 95: 71-78.
39. WELLE, S. & R.G. CAMPBELL. 1984. Effect of overeating on plasma and urinary concentrations of norepinephrine. J. Clin. Endocrinol. Metab. 59: 531-534.
40. WELLE, S. & R.G. CAMPBELL. 1983. Stimulation of thermogenesis by carbohydrate overfeeding. Evidence against sympathetic nervous system activation. J. Clin. Invest. 71: 916-925.
41. WELLE, S., U. LILAVIVAT & R.G. CAMPBELL. 1981. Thermic effect of feeding in man: increased plasma norepinephrine levels following glucose but not protein or fat consumption. Metabolism 30: 953-958.
42. MACDONALD, I.A., T. BENNETT & I.W. FELLOWS. 1985. Catecholamines and the control of metabolism in man. Clin. Sci. 68: 613-619.
43. ACHESON, K.J., E. RAVUSSIN, D.A. SCHOELLER, et al. 1988. Two-week stimulation or blockade of the sympathetic nervous system in man: influence on body weight, body composition and twenty four-hour energy expenditure. Metabolism 37: 91-98.
44. WELLE, S., R.G. SCHWARTZ & M. STATT. 1991. Reduced metabolic rate during β-adrenergic blockade in humans. Metabolism 40: 619-622.
45. SCHWARTZ, R.S., L.F. JAEGER & R.C. VEITH. 1988. Effect of clonidine on the thermic effect of feeding in humans. Am. J. Physiol. 254: R90-R94.
46. BLAAK, E.E., W.H.M. SARIS & M.A. VAN BAAK. 1993. Adrenoceptor subtypes mediating catecholamine-induced thermogenesis in man. Int. J. Obes. Relat. Metab. Disord. 17(Suppl 3): S78-S81.
47. WELLE, S. 1995. Sympathetic nervous system response to intake. Am. J. Clin. Nutr. 62(Suppl 5): S1118-S1122.
48. VOLLENWEIDER, P., L. TAPPY, D. RANDIN, et al. 1993. Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J. Clin. Invest. 92: 147-154.
49. BLAAK, E.E., M.A. VAN BLAAK, A.D.M. KESTER, et al. 1995. β-adrenergically mediated thermogenic and heart rate responses: effect of obesity and weight loss. Metabolism 44: 520-524.
50. TENTOLOURIS, N., C. TSIGOS, N. KATSILAMBROS, et al. 2003. Differential effects of high-fat and high-carbohydrate isoenergetic meals on cardiac autonomic nervous system activity in lean and obese women. Metabolism 52: 1426-1432.
51. SHARMA, A.M., T. PISCHON, S. HARDT, et al. 2001. Hypothesis: β-adrenergic blockers and weight gain. A systematic analysis. Hypertension 37: 250-254.
52. HEINONEN, P., M. KOULOU, U. PESONEN, et al. 1999. Identification of a three-aminoacid deletion in the alpha2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. J. Clin. Endocrinol. Metab. 84: 2429-2433.
53. 2B adrenergic receptor deletion/insertion polymorphism in morbid obesity. Clin. Auton. Res. 13: 203-207.
54. OOMEN, J.M., C.T. VAN ROSSUM, B. HOEBEE, et al. 2005. beta2-adenergic receptor polymorphisms and salbutamol-stimulated energy expenditure. J. Clin. Endocrinol. Metab. 90: 2301-2307.
55. GARENC, C., L. PERUSSE, Y.C. CHAGNON, et al. 2003. Effects of beta2-adrenergic receptor gene variants on adipocity: the HERITAGE Family Study. Obes. Res. 11: 612-618.
56. LEINEWEBER, K., R. BUSCHER & H. BRUCK. 2004. β-adrenoceptor polymorphisms. Naunyn Schmiedebergs Arch. Pharmacol. 369: 1-22.
57. RAVUSSIN, E., S. LILLIOJA, T.E. ANDERSON, et al. 1986. Determinants of 24-hour energy expenditure in man: methods and results using a respiratory chamber. J. Clin. Invest. 78: 1568-1575.
58. HILL, J.O., M. DIGIROLAMO & S.B. HEYMSFIELD. 1985. Thermic effect of food after ingested versus tube delivered meals. Am. J. Physiol. 248: E370-E374.
59. ACHESON, K.J., E. RAVUSSIN, J. WAHREN, et al. 1984. Thermic effect of glucose in man. Obligatory and facultative thermogenesis. J. Clin. Invest. 70: 1570-1580.
60. ROWE, J.W., J.B. YOUNG, K.L. MINAKER, et al. 1981. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 30: 219-225.
61. ASTRUP, A., S. TOUBRO, S. CANNON, et al. 1990. Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am. J. Clin. Nutr. 51: 759-767.
62. ASTRUP, A., S. TOUBRO, S. CANNON, et al. 1990. Thermogenic, metabolic, and cardiovascular effects of a sympathomimetic agent, ephedrine. Curr. Ther. Res. Exp. 48: 1087-1100.
63. WELLE, S.L., K.S. NAIR & R.G. CAMPBELL. 1989. Failure of chronic β-adrenergic blockade to inhibit overfeeding-induced thermogenesis in humans. Am. J. Physiol. 256: R653-R658.
64. ROTHWELL, N.J. & M.J. STOCK. 1979. A role for brown adipose tissue in diet-induced thermogenesis. Nature 281: 31-35.
65. WELLE, S., T.B. SEATON & R.G. CAMPBELL. 1986. Some metabolic effects of overeating in man. Am. J. Clin. Nutr. 44: 718-724.
66. ASTRUP, A., B. BUEMANN, N.J. CHRISTENSEN, et al. 1992. 24-Hour energy expenditure and sympathetic activity in postobese women consuming a high-carbohydrate diet. Am. J. Physiol. 262: E282-E288.
67. TATARANNI, P.A., J.B. YOUNG, C. BOGARDUS, et al. 1997. A low sympathoadrenal activity is associated with body weight gain and development of central adiposity in Pima Indian men. Obes. Res. 5: 341-347.
68. WALSTON, J., K. SILVER, C. BOGARDUS, et al. 1995. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β3-adrenergic-receptor gene. N. Engl. J. Med. 333: 343-347.
69. ASTRUP, A., B. BUEMANN, C. GLUUD, et al. 1995. Prognostic markers for diet-induced weight loss in obese women. Int. J. Obes. Relat. Metab. Disord. 19: 275-278.
70. YOUNG, J.B. & I.A. MACDONALD. 1992. Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int. J. Obes. Relat. Metab. Disord. 16: 959-967.
71. VOLLENWEIDER, P., D. RANDIN, L. TAPPY, et al. 1994. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J. Clin. Invest. 93: 2365-2371.
72. GRASSI, G., G. SERAVALLE, B.M. CATTANEO, et al. 1995. Sympathetic activation in obese normotensive subjects. Hypertension 25: 560-563.
73. POEHLMAN, E.T., A.W. GARDNER, M.I. GORAN, et al. 1995. Sympathetic nervous system activity, body fatness and body fat distribution in younger and older males. J. Appl. Physiol. 78: 802-806.
74. MUSCELLI, E., M. EMDIN, A. NATALI, et al. 1998. Autonomic and hemodynamic responses to insulin in lean and obese humans. J. Clin. Endocrinol. Metab. 83: 2084-2090.
75. PAOLISSO, G., D. MANZELLA, N. FERRARA, et al. 1997. Glucose ingestion affects cardiac ANS in healthy subjects with different amounts of body fat. Am. J. Physiol. 273: E471-E478.
76. LAEDERACH-HOFMANN, K., L. MUSSGAY, H. RUDDEL. 2000. Autonomic cardiovascular regulation in obesity. J. Endocrinol. 164: 59-66.
77. PICCIRILLO, G., F. VETTA, E. VIOLA, et al. 1998. Heart rate and blood pressure variability in obese normotensive subjects. Int. J. Obes. Relat. Metab. Disord. 22: 741-750.
78. BESKE, S.D., G.E. ALVAREZ, T.P. BALLARD, et al. 2002. Reduced cardiovagal baroreflex gain in visceral obesity: implications for the metabolic syndrome. Am. J. Physiol. Heart Circ. Physiol. 282: H630-H635.
79. HEART RATE VARIABILITY. STANDARDS OF MEASUREMENT, PHYSIOLOGICAL INTERPRETATION, AND CLINICAL USE. 1996. Task Force of the European Society of Cardiology the North American Society of Pacing Electrophysiology. Circulation 93: 1043-1065.
80. LANDSBERG, L. & D.R. KRIEGER. 1989. Obesity, metabolism and the sympathetic nervous system. Am. J. Hypertens. 2: 125S-132S.
81. TENTOLOURIS, N., E. GRAPSAS, E. STAMBULIS, et al. 1999. Impact of body mass on autonomic function in persons with type 2 diabetes. Diab. Res. Clin. Pract. 46: 29-33.
82. PAOLISSO, G., D. MANZELLA, M.R. RIZZO, et al. 2000. Elevated plasma fatty acid concentrations stimulate the cardiac autonomic nervous system in healthy subjects. Am. J. Clin. Nutr. 72: 723-730.
83. VGONTZAS, A.N., E.O. BIXLER & G.P. CHROUSOS. 2003. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J. Intern. Med. 254: 32-44.
84. PEPPARD, P.E., T. YOUNG, M. PALTA, et al. 2000. Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med. 342: 1378-1384.
85. AMERICAN THORACIC SOCIETY/AMERICAN SLEEP DISORDERS ASSOCIATION. 1998 Statement on health outcomes research in sleep apnea. Am. J. Respir. Crit. Care Med. 157: 335-341.
86. JO, J.A., A. BLASI, E. VALLADARES, et al. 2003. Model-based assessment of autonomic control in obstructive sleep apnea syndrome during sleep. Am. J. Respir. Crit. Care Med. 167: 128-136.
87. YOUNG, J.B. & L. LANDBERG. 1977. Suppression of sympathetic nervous system during fasting. Science 196: 1473-1475.
88. DEHAVEN, J., R. SHERWIN, R. HENDLER, et al. 1980. Nitrogen and sodium balance and sympathetic nervous system activity in obese subjects treated with a low-caloric protein or mixed diet. N. Engl. J. Med. 302: 477-482.
89. WELLE, S. 1989. Dietary effects on thermogenesis in man: role of norepinephrine and triiodothyronine. In Hormones, Thermogenesis and Obesity. H. Lardy & F. Stratman, Eds.: 279-288. Elsevier Science. New York.
90. JUNG, R.T., P.S. SHETTY, M. BARRAND, et al. 1979. Role of catecholamines in hypotensive response to dieting. Br. Med. J. 6155: 12-13.
91. SCHERRER, U. & C. SARTORI. 1997. Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 96: 4104-4113.
92. PAOLISSO, G., D. MANZELLA, M.R. TAGLIAMONTE, et al. 1999. Effects of different insulin infusion rates on heart rate variability in lean and obese subjects. Metabolism 48: 755-762.
93. BERGHOLM, R., J. WESTERBACKA, S. VEHKAVAARA, et al. 2001. Insulin sensitivity regulates autonomic control of heart rate variation independent of body weight in normal subjects. J. Clin. Endocrinol. Metab. 86: 1403-1409.
94. PAOLISSO, G., D. MANZELLA, M.R. RIZZO, et al. 2000. Effects of insulin on the cardiac autonomic nervous system in insulin-resistant states. Clin. Sci. (Lond.) 98: 129-136.
95. SEALS, D.R. & C. BELL. 2004. Chronic sympathetic activation: consequence and cause of age-associated obesity? Diabetes 53: 276-284.
96. PELLEYMOUNTER, M.A., M.J. CULLEN, M.B. BAKER, et al. 1995. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543.
97. CARLYLE, M., O.B. JONES, J.J. KUO, et al. 2002. Chronic cardiovascular and renal actions of leptin. Role of adrenergic activity. Hypertension 39: 496-501.
98. LAMOUNIER-ZEPTER, V., S.R. BORNSTEIN & M. EHRHART-BORNSTEIN. 2004. Mechanisms of obesity-related hypertension. Horm. Metab. Res. 36: 376-380.
99. MARK, A.L., M.L.G. CORREIA, K. RAHMOUNI, et al. 2002. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J. Hypertens. 20: 1245-1250.
100. SATOH, N., Y. OGAWA, G. KATSUURA, et al. 1999. Sympathetic activation of leptin via the ventromedial hypothalamus. Leptin-induced increase in catecholamine secretion. Diabetes 48: 1787-1793.
101. HAYNES, W.G. 2000. Interaction between leptin and sympathetic nervous system in hypertension. Curr. Hypertens. Rep. 2: 311-318.
102. PAOLISSO, G., D. MANZELLA, N. MONTANO, et al. 2000. Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights. J. Clin. Endocrinol. Metab. 85: 1810-1814.
103. GUHA, P.K., D. VILLARREAL, G. REAMS, et al. 2003. Role of leptin in the regulation of body fluid volume and pressures. Am. J. Ther. 10: 211-218.
104. POIRIER, P., T.L. HERNANDEZ, K.M. WEIL, et al. 2003. Impact of diet-induced weight loss on the cardiac autonomic nervous system in severe obesity. Obes. Res. 11: 1040-1047.
105. ARONE, L.J., R. MACKINTOSH, M. ROSENBAUM, et al. 1995. Autonomic nervous system activity in weight gain and weight loss. Am. J. Physiol. 269: R222-R225.
106. EMDIN, M., A. GASTALDELLI, E. MUSCELLI, et al. 2001. Hyperinsulinemia and autonomic nervous system dysfunction in obesity. Effects of weight loss. Circulation 103: 513-519.
107. KARASON, K., H. MOLGAARD, J. WIKSTRAND, et al. 1999. Heart rate variability in obesity and the effect of weight loss. Am. J. Cardiol. 83: 1242-1247.
108. LAAKSONEN, D.E., T. LAITINEN, J. SCHONBERG, et al. 2003. Weight loss and weight maintenance, ambulatory blood pressure and cardiac autonomic tone in obese persons with the metabolic syndrome. J. Hypertens. 21: 371-378.
109. GRASSI, G., G. SERAVALLE, M. COLOMBO, et al. 1998. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation 97: 2037-2042.
110. P. BJÖRNTORP. 2001. Do stress reactions cause abdominal obesity and comorbidities? Obes. Rev. 12: 73-86.
111. GRASSI, G., G. SERAVALLE, R. DELL'ORO, et al. 2001. Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity. Hypertension 38: 1316-1320.
112. CHROUSOS, G. 2000. The role of stress and the hypothalamic-pituitary- adrenal axis in the pathogenesis of the metabolic syndrome: neuroendocrine and target tissue-related causes. Int. J. Obes. Relat. Metab. Disord. 24(Suppl 2): S50-S55.
113. BJÖRNTORP, P. & R. ROSMOND. 2000. The metabolic syndrome-a neuroendocrine disorder? Br. J. Nutr. 83(Suppl 1): S49-S57.
114. BUSETTO, L. 2001. Visceral obesity and the metabolic syndrome: effects of weight loss. Nutr. Metab. Cardiov. Dis. 11: 195-204.
115. RUPP, H. & B. MAISCH. 2003. Abdominal fat and sympathetic overactivity. From caloric intake to postmenopausal hypertension. Herz 28: 668-673.
116. ALVAREZ, G.E., S.D. BESKE & T.P. BALLARD, DAVY, K.P. 2002. Sympathetic neural activation in visceral obesity. Circulation 106: 2533-2536.
117. HUGGETT, R.J., I. BURNS, A.F. MACKINTOSH, et al. 2004. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 44: 847-852.
118. PIKKUJAMSA, S.M., H.V HUIKURI, K.E.J. AIRAKSINEN, et al. 1998. Heart rate variability and baroreflex sensitivity in hypertensive subjects with and without metabolic features of insulin resistance syndrome. Am. J. Hypertens. 11: 523-531.
119. LIAO, D., R.P. SLOAN, W.E. CASCIO, et al. 1998. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Community Study. Diabetes Care 21: 2116-2122.
120. GRASSI, G., R. DELL'ORO, F. QUARTI-TREVANO, et al. 2005. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia. 48: 1359-1365.
121. BRUNNER, E.J., H. HEMINGWAY, B.R. WALKER, et al. 2002. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome. Nested case-control study. Circulation 106: 2659-2665.
122. LJUNG, T., G. HOLM, P. FRIBERG, et al. 2000. The activity of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system in relation to waist/hip circumference ratio in men. Obes. Res. 8: 487-495.
123. JONES, P.P., S. SNITKER, J.S. SKINNER, et al. 1996. Gender differences in muscle sympathetic nerve activity; effect of body fat distribution. Am. J. Physiol. 270: E363-E366.
124. PEHLMAN, E.T., M.J. TOTH, A.W. GARDNER. 1995. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann. Intern. Med. 123: 673-675.
125. TOTH, M.J., A.M. TCHERNOF, C.K. SITES, et al. 2000. Effect of menopausal status on body composition and abdominal fat distribution. Int. J. Obes. Relat. Metab. Disord. 24: 226-231.
126. SUMINO, H., A. ICHIKAWA, A. YOSHIDA, et al. 2003. Effects of hormone replacement therapy on weight, abdominal fat distribution, and plasma lipid levels in Japanese postmenopausal women. Int. J. Obes. Relat. Metab. Disord. 27: 1044-1051.
127. VONGOPATANASIN, W., M. TUNCEL, Y. MANSOUR, et al. 2001. Thransdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women. Circulation 103: 2903-2908.
128. WEITZ, G., M. ELAM, J. BORN, et al. 2001. Postmenopausal estrogen administration suppresses muscle sympathetic nerve activity. J. Clin. Endocrinol. Metab. 86: 344-348.
129. OSTMAN, J., P. ARNER, P. ENGFELDT, et al. 1979. Regional differences in the control of lipolysis in human adipose tissue. Metabolism 28: 1198-1205.
130. BUSETTO, L., M. DIGITO, P. DALLA MONTA, et al. 1993. Omental and epigastric adipose tissue lipolytic activity in human obesity: effect of abdominal fat distribution and relationship with hyperinsulinaemia. Horm. Metab. Res. 25: 365-371.
131. HOFFSTEDT, J., H. WAHRENBERG, A. THORNE, et al. 1996. The metabolic syndrome is related to beta 3-adrenoceptor sensitivity in visceral adipose tissue. Diabetologia 39: 838-844.
132. BUSETTO, L., A. TREGNAGHI, M. BUSSOLOTTO, et al. 2000. Visceral fat loss evaluated by total body magnetic resonance imaging in obese women operated with laparoscopic adjustable silicone gastric banding. Int. J. Obes. Relat. Metab. Disord. 24: 60-69.
133. BARZILAI, N., J. WANG, D. MASSILON, et al. 1997. Leptin selectively decreases visceral adiposity and enhances insulin action. J. Clin. Invest. 100: 3105-3110.
134. BARZILAI, N., L. SHE, L. LIU, et al. 1999. Decreased visceral adiposity accounts for leptin's effect on hepatic but non peripheral insulin action. Am. J. Physiol. 277: E291-E298.
135. CHROUSOS, G.P. 1995. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332: 1351-1362.
136. MOHAMED-ALI, V., K. BULMER, D. CLARKE, et al. 2000. β-adrenergic regulation of proinflammatory cytokines in humans. Int. J. Obes. Relat. Metab. Disord. 24(Suppl 2): S154-S155.